AI
FLGT icon

Atom Investors’s Fulgent Genetics FLGT Stock Holding History

Atom Investors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$421K Buy
+20,529
New +$348K 0.04% 610
2025
Q4 		– Sell
-18,965
Closed -$429K – 659
2025
Q3 		$429K Buy
18,965
+1,708
+10% +$35.2K 0.03% 379
2025
Q2 		$343K Buy
17,257
+3,087
+22% +$60.2K 0.03% 414
2025
Q1 		$239K Buy
+14,170
New +$241K 0.03% 390
2024
Q2 		– Sell
-17,672
Closed -$383K – 543
2024
Q1 		$383K Buy
+17,672
New +$439K 0.05% 374

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Atom Investors's FLGT Position: Q2 2026 in Review

Atom Investors opened a new position in Fulgent Genetics (FLGT) in Q2 2026: 20,529 shares worth $421K. The stake represents 0.04% of the portfolio and ranks #610 among its holdings. This is a return to the name: Atom Investors previously reported a position in FLGT as recently as Q3 2025.

Atom Investors first reported a position in FLGT in Q1 2024 and has held it in 5 quarters since. The position peaked at $429K in Q3 2025. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Atom Investors held 20,529 shares of Fulgent Genetics worth $421K as of Q2 2026.
  • Fulgent Genetics was a new Atom Investors position in Q2 2026.
  • Fulgent Genetics made up 0.04% of Atom Investors's portfolio in Q2 2026, its #610 holding.
  • Atom Investors first reported a position in Fulgent Genetics in Q1 2024 and has held it in 5 quarters since.
  • Atom Investors's Fulgent Genetics position peaked at $429K in Q3 2025.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.